RUA Life Sciences plc (RUA) is a Medical devices company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for RUA Life Sciences plc in 2026. The next earnings report is expected on July 19, 2027.
Next earnings date
19 Jul 2027
In 333 days
EPS estimate
—
Revenue estimate
3.4M
Past earnings
No dividend history available.
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.
RUA Life Sciences plc (RUA) is scheduled to report earnings on July 19, 2027.
RUA Life Sciences plc (RUA) last reported earnings on June 10, 2026.
RUA Life Sciences plc (RUA) is listed on London Exchange.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.